Expression and molecular profiles of the AlkB family in ovarian serous carcinoma

被引:3
|
作者
Cai, Yuan [1 ]
Wu, Geting [1 ]
Peng, Bi [1 ]
Li, Juanni [1 ]
Zeng, Shuangshuang [2 ]
Yan, Yuanliang [2 ]
Xu, Zhijie [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 07期
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
ovarian serous carcinoma; AlkB family; expression profiles; infiltrating immune cells; methylation; CANCER PROGRESSION; M(6)A;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AlkB family of Fe (II) and alpha-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. KaplanMeier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients.
引用
收藏
页码:9679 / 9692
页数:14
相关论文
共 50 条
  • [31] Apolipoprotein E expression in ovarian serous carcinoma and other types
    Cheng, CC
    Chen, YC
    Maitra, A
    Hruban, RH
    Gabrison, E
    Kurman, RJ
    Shih, IM
    MODERN PATHOLOGY, 2003, 16 (01) : 186A - 186A
  • [32] Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
    Katarzyna M. Lisowska
    Magdalena Olbryt
    Sebastian Student
    Katarzyna A. Kujawa
    Alexander J. Cortez
    Krzysztof Simek
    Agnieszka Dansonka-Mieszkowska
    Iwona K. Rzepecka
    Patrycja Tudrej
    Jolanta Kupryjańczyk
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1239 - 1252
  • [33] Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
    Lisowska, Katarzyna M.
    Olbryt, Magdalena
    Student, Sebastian
    Kujawa, Katarzyna A.
    Cortez, Alexander J.
    Simek, Krzysztof
    Dansonka-Mieszkowska, Agnieszka
    Rzepecka, Iwona K.
    Tudrej, Patrycja
    Kupryjanczyk, Jolanta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1239 - 1252
  • [34] Molecular profile of uterine papillary serous carcinoma compared to ovarian serous carcinoma: Is it the same disease at different site?
    Mahdi, H.
    Xiu, J.
    Reddy, S. K.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 153 - 154
  • [35] Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
    Santin, AD
    Zhan, FH
    Bellone, S
    Palmieri, M
    Cane, S
    Bignotti, E
    Anfossi, S
    Gokden, M
    Dunn, D
    Roman, JJ
    O'Brien, TJ
    Tian, EM
    Cannon, MJ
    Shaughnessy, J
    Pecorelli, S
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) : 14 - 25
  • [36] Amplicon profiles in ovarian serous carcinomas
    Nakayama, Kentaro
    Nakayama, Naomi
    Jinawath, Natini
    Salani, Ritu
    Kurman, Robert J.
    Shih, Ie-Ming
    Wang, Tian-Li
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (12) : 2613 - 2617
  • [37] Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study
    Karin-Kujundzic, Valentina
    Kardum, Vedran
    Sola, Ida Marija
    Paic, Frane
    Skrtic, Anita
    Skenderi, Faruk
    Serman, Alan
    Nikuseva-Martic, Tamara
    Vranic, Semir
    Serman, Ljiljana
    APMIS, 2020, 128 (03) : 201 - 210
  • [38] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [39] Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
    Kurman, R. J.
    ANNALS OF ONCOLOGY, 2013, 24 : 16 - 21
  • [40] The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
    Davidson, B.
    CYTOPATHOLOGY, 2011, 22 (01) : 5 - 21